Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2025-09-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(약식)' which translates to 'Report on Large Shareholding Status (Abbreviated)'. It details the ownership of shares and convertible bonds by a specific investor (주식등의 대량보유상황보고서 means Large Shareholding Report). It includes information about the number of shares held, changes in holdings, and the purpose of holding shares. The document references the Capital Markets Act and is a regulatory filing related to disclosure of significant share ownership. This matches the definition of Major Shareholding Notification (Code: MRQ), which is for notifications of changes in significant share ownership levels crossing thresholds. The document is about reporting a new acquisition of convertible bonds leading to a significant shareholding percentage (13.68%). It is not an annual report, earnings release, or any other type of report. Therefore, the correct classification is MRQ with high confidence.
2025-09-29 Korean
주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 75% confidence The document is a notice of the convocation of an extraordinary shareholders’ meeting (“주주총회소집결의”) with date, time, location, and agenda items provided to shareholders. It is not financial statements, audit, results announcement, or board changes. It constitutes proxy/materials sent to shareholders to inform and request votes on meeting agenda, fitting the Proxy Solicitation & Information Statement category (PSI).
2025-09-25 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 82% confidence The document is a short corporate announcement in Korean regarding the setting of a record date (shareholders register closure period) for an extraordinary general meeting. It does not contain financial statements, dividend details, vote results, or materials from the meeting itself, but rather a notice of a corporate action. As such, it does not fit into any specialized category like DIV, DVA, PSI, or AGM materials, and should be classified under the fallback category for general regulatory announcements.
2025-09-25 Korean
기타시장안내(최대주주의의무보유관련)
Regulatory Filings Classification · 85% confidence The notice is a compliance announcement submitted to the stock exchange regarding the major shareholder’s mandatory lock-up of newly acquired shares. It does not itself present financial results, dividend details, or constitute the actual capital increase report, nor is it a full report like an annual or interim report. This general regulatory announcement fits the fallback ‘Regulatory Filings’ category.
2025-09-23 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 92% confidence The document is a voluntary disclosure in Korean describing the issuance results of the company’s 16th series private placement convertible bonds, including issuance amount, resolution date, payment date, and listing plans. This is a direct update on the company’s financing activity (capital raising) rather than a periodic report or regulatory certification. Therefore, it fits the “Capital/Financing Update” category.
2025-09-22 Welsh
주요사항보고서(영업정지)
Regulatory Filings Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding the suspension of business operations (영업정지) for the healthcare division of Alpha AI (formerly Alphanox). This is a regulatory disclosure of a significant corporate event. Since it does not fit into specific categories like M&A, dividend announcements, or financial reports, it falls under the general regulatory filing category.
2025-09-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.